| 
      
        | Your Current Location : Fund Card : Portfolio Classification |  
        | 
          
          
            |                   
                  
                  
                    | 
                    
                        |  |  
                        |  |  
                        |  |  
                        | 
                          
                            | 
                                
                                  | ICICI Pru Nifty Pharma Index Fund IDCW Direct |  
                                     | [Equity: Index] |  |  
                            |  |  
                            | 
                              
                                |  |  | 
                                  
                                    | Instruments Breakdown |  
                                    | Instruments | Composition |  
                                    | Current Asset | -0.33 |  
                                    | Equity | 99.88 |  
                                    | Trep | 0.45 |  |  
                                |  |  
                                | 
                                  
                                    | Concentration Analysis |  
                                    | 
                                      
| Top 5 Holdings | 58.99% |  
| Top 10 Holdings | 79.05% |  
| Top 25 Holdings | 100.00% |  |  |  |  
                            |  |  
                            | 
                              
                                | 
                                  
                                    | Sector Analysis |  
                                    | 
                                        
                                          | Sector/Ratings | Net Asset(%) |  
| Pharma & Biotech | 99.88 |  
| Cash | 0.12 |  |  
                                    |  |  |  | 
                                  
                                    	
                                    
                                    | 
                                      
                                        | Portfolio Metrics |  |  
                                        | PB Ratio | 5.02 |  
                                        | PE Ratio | 33.47 |  |  
                                    |  |  
                                    | 
                                  
                                    | Top 25 Holdings |  
                                      |  |  
                                    | 
                                            
                                                | Holdings | Net Asset(%) |  
| Sun Pharmaceutical Industries Limited | 21.97 |  
| Cipla Limited | 11.42 |  
| DIVI LABORATORIES LTD | 9.95 |  
| Dr Reddys Laboratories Limited | 9.80 |  
| Lupin Limited | 5.85 |  
| Torrent Pharmaceuticals Limited | 4.76 |  
| Laurus Labs Limited | 4.29 |  
| Glenmark Pharmaceuticals Limited | 3.70 |  
| Aurobindo Pharma Limited | 3.67 |  
| Alkem Laboratories Limited | 3.64 |  
| MANKIND PHARMA LIMITED | 3.57 |  
| Zydus Lifesciences Limited | 3.13 |  
| Biocon Limited | 2.67 |  
| IPCA Laboratories Limited | 2.46 |  
| Abbott India Limited | 2.09 |  
| Gland Pharma Limited | 1.90 |  
| J B Chemicals and Pharma Ltd | 1.78 |  
| Ajanta Pharma Limited | 1.33 |  
| Natco Pharma Limited | 0.99 |  
| Granules India Limited | 0.91 |  
| Tri Party Repo | 0.45 |  
| Net Current Assets | -0.33 |  |  |  |  
                                |  |  |  
                            |  |  
                            | Sector Analysis Graphical Mode |  
                            |  |  
                            |  |  |  |  
                    |  |  |  |  
            |  |  |  | 
  
    |  |